Study shows economic benefit of EECP (enhanced external counterpulsation):
This article was originally published in Clinica
Use of Vasomedical's enhanced external counterpulsation (EECP) therapy in patients with chronic, refractory angina results in a significant reduction in the number of inpatient hospital days in the first year after treatment, according to an Irish study presented at the British Cardiac Society meeting in May. The study was the first to demonstrate an economic benefit of EECP. Data from a US study presented at the same meeting supported the use of EECP as initial treatment in patients with angina or chest pain.